Mochida Pharmaceutical Co., Ltd.

Tetsushi Kawahara

Shoji Furusako

Yoshitaka Hosaka

Kamon Shirakawa

Tomokazu Matsusue

Katsuki Naitoh

Motoyasu Honda

Yumi Hotta

Hiroshi Takayama

Takashi Takeuchi

Masaki Nakamura

Kazuyuki Nakayama

A protein comprising (I) an anti-CDantibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided.

Polynucleotide encoding anti-CD14 antibody fusion protein

The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof: a) It specifically binds to human platelet membrane glycoprotein VI (GPVI); b) The function to activate a platelet and/or the function to induce a thrombocytopenia in vivo are low; and c) It at least partially depletes GPVI on the platelet membrane by contacting with a platelet.

Anti-platelet membrane glycoprotein VI monoclonal antibody

The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof:

A protein comprising (I) an anti-CD14 antibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided.

Anti-CD14 antibody fusion protein

Growing community of inventors

Tokyo, Japan

Tetsushi Kawahara